Open AccessComparative Analysis of the Effects of Escitalopram, Pramipexole, and Transcranial Magnetic Stimulation on Depression in Patients With Parkinson Disease: An Open-Label Randomized Controlled Trial
Author(s) -
Jing Chen,
Pengfei Xu,
Xunyi Guo,
Tao Zou
Publication year - 2022
Publication title -
clinical neuropharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.486
H-Index - 78
eISSN - 1537-162X
pISSN - 0362-5664
DOI - 10.1097/wnf.0000000000000507
Subject(s) - escitalopram , pramipexole , hamd , depression (economics) , medicine , parkinson's disease , randomized controlled trial , statistical significance , psychology , transcranial magnetic stimulation , antidepressant , major depressive disorder , clinical global impression , disease , stimulation , placebo , significant difference , alternative medicine , macroeconomics , pathology , amygdala , hippocampus , economics
This study aimed to compare the effects of different antidepressant therapies on depression in patients with Parkinson disease (PD) and to provide a reference for clinical treatment.